These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9752347)
21. [Percutaneous radiotherapy of oropharyngeal and hypopharyngeal cancer]. Sauer R Sonderb Strahlenther Onkol; 1987; 81():32-43. PubMed ID: 3824130 [No Abstract] [Full Text] [Related]
22. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Semrau R; Mueller RP; Stuetzer H; Staar S; Schroeder U; Guntinas-Lichius O; Kocher M; Eich HT; Dietz A; Flentje M; Rudat V; Volling P; Schroeder M; Eckel HE Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1308-16. PubMed ID: 16464538 [TBL] [Abstract][Full Text] [Related]
23. [New knowledge about late sequelae of radiochemotherapy]. Budach W HNO; 1998 Aug; 46(8):708-11. PubMed ID: 9773327 [No Abstract] [Full Text] [Related]
24. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968 [TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158 [TBL] [Abstract][Full Text] [Related]
26. Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Kazi R; Venkitaraman R; Johnson C; Prasad V; Clarke P; Rhys-Evans P; Nutting CM; Harrington KJ Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):344-52. PubMed ID: 17881146 [TBL] [Abstract][Full Text] [Related]
27. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck]. Wendt TG Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396 [No Abstract] [Full Text] [Related]
28. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx. Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341 [TBL] [Abstract][Full Text] [Related]
29. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)]. Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Ambrosch P; Kron M; Pradier O; Steiner W Otolaryngol Head Neck Surg; 2001 Feb; 124(2):180-7. PubMed ID: 11226954 [TBL] [Abstract][Full Text] [Related]
32. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
33. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617 [TBL] [Abstract][Full Text] [Related]
34. [Organ preservation in laryngeal and hypopharyngeal cancer]. Quer M; León X Acta Otorrinolaringol Esp; 2007 Dec; 58(10):476-82. PubMed ID: 18082078 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic options for laryngeal cancer. Vokes EE; Stenson KM N Engl J Med; 2003 Nov; 349(22):2087-9. PubMed ID: 14645634 [No Abstract] [Full Text] [Related]
38. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa]. Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474 [TBL] [Abstract][Full Text] [Related]
39. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464 [TBL] [Abstract][Full Text] [Related]